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Colorectal Cancer — Research
for colonoscopy, regardless of the indication 
for the investigation. Studies of screening 
colonoscopy in asymptomatic people sug-
gest that up to 1% of men and 0.1% of 
women in the age group 55–74 years have 
invasive malignancy.1,2







Objective:  To evaluate whether prolonged waiting times for colonoscopy in public 
hospitals could result in delayed diagnosis of colorectal carcinoma.
Design, setting and patients:  Analysis of all outpatient colonoscopies performed at a 
Western Australian tertiary teaching hospital, 1 November 2003 – 31 October 2005. 
Colonoscopy data, corresponding pathological findings, category of urgency at referral 
for colonoscopy, and waiting time for colonoscopy were obtained. Patients were coded 
as having cancer if it was diagnosed by colonoscopy or if colonoscopy identified a lesion 
equently diagnosed as cancer.
 outcome measures:  Colorectal carcinoma detected by outpatient colonoscopy 
ength of waiting time to colonoscopy.
lts:  1632 outpatient colonoscopies were recorded. Category I patients received a 
oscopy within the recommended 30 days from referral. Median waiting times for 
gory II and Category III patients exceeded recommendations (observed, 113 days 
and 258 days; recommended, within 90 days and 180 days, respectively), although the 
number of cancers detected was low (2.4% and 0.6% of referrals, respectively in each 
category). Early- and late-stage cancers had similar median waiting times from referral to 
diagnosis. Age over 65 years and the blood-loss indications — a positive faecal occult 
blood test or iron deficiency/anaemia — were predictors of an increased risk of 
carcinoma at colonoscopy.
Conclusions:  Waiting time for colonoscopy was not associated with an increase in the 
proportion of late-stage cancers diagnosed. Age over 65 years and evidence of blood 
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loss increased the likelihood of a cancer diagnosis.
For editorial comment, see page 280ith
the
foW in the public health system, re can be long waiting times r some endoscopic proce-
dures. With colonoscopy, this can cause 
concern, as this procedure is often per-
ceived as a cancer exclusion test. Because 
colorectal cancer (CRC) is a common inter-
nal malignancy in Western countries, it is 
likely to be present in some people waiting 
screening program would increase the 
demand for colonoscopy, with the risk of 
diverting resources from people with symp-
toms of CRC. The experience of the Bowel 
Cancer Screening Pilot Program in Australia 
suggests that increased demand can come 
from non-participants as well as those with 
positive results of a faecal occult blood test 
(FOBT).3 As a result, waiting times can 
increase, but this can depend on various 
factors, such as the rate of positive test 
results in the program.3 Within an FOBT-
based screening trial conducted in the 
United Kingdom, the number of hospital 
colonoscopies at participating sites 
increased by 20%–30%, which increased 
average waiting times for symptomatic 
patients from 10 to nearly 18 weeks.4
Like many institutions, Fremantle Hospi-
tal in Western Australia has experienced 
increasing difficulty in meeting recom-
mended waiting times for semi-urgent and 
routine colonoscopy. A waiting-list reduc-
tion initiative was introduced by the state 
government in 2004.
We aimed to determine whether 
increased waiting times were associated 
with a more advanced stage of carcinoma 
diagnosed by colonoscopy; to identify fac-
tors that predict a diagnosis of CRC; and to 
evaluate the impact of the government’s 
waiting-list strategy.
METHODS
Fremantle Hospital is a 450-bed tertiary 
hospital with two endoscopic procedural 
rooms. Generally, about 25 colonoscopies 
are performed each week.
Records of outpatient colonoscopies per-
formed at Fremantle Hospital were extracted 
from an electronic database for endoscopy 
reporting for the time period 1 November 
2003 to 31 October 2005. If the reported 
findings included pathological changes, the 
corresponding histopathology results were 
obtained to determine the presence of CRC. 
Any duplicated records within the databases 
were deleted and, when a patient had had 
multiple procedures, only the first colonos-
copy was included in the study. We 
excluded patients who had undergone a 
colonoscopy in the 6 months before the 
study period, as these would not reflect new 
outpatient referrals.
Colonoscopy records were linked to a 
central hospital network to obtain the date 
of listing of the colonoscopy request and the 
triaged category of urgency. Fremantle Hos-
pital uses three categories of clinical 
urgency: Category I (recommended to have 
procedure within 30 days), Category II (pro-
cedure within 90 days) and Category III 
(procedure within 180 days). All referrals 
received by the Endoscopy Unit are 
reviewed by a gastroenterologist on a daily 
basis to determine the suitability for colon-
oscopy and the clinical urgency of the refer-
ral. Procedures are then booked directly or 
the patient is seen at the clinic for further 
assessment before scheduling the colonos-
copy. All procedures are arranged through 
the public system. The number of days on 
the waiting list was determined from the 
date of listing and the date of colonoscopy.
Patients were also categorised by the indi-
cation for colonoscopy. As the endoscopy 
reporting program allows a large number of 
indication selections, we chose broad group-
ings comprising:
• Blood-loss indications — rectal bleeding, 
melaena, anaemia (haemoglobin level less 
than the normal sex-specific range or anae-
mia reported in the referral), a positive 
FOBT result, or iron deficiency (serum ferri-
tin level below the normal sex-specific range 
or deficiency reported in the referral);
• Follow-up examination — if the term “fol-
low-up” was included as an indication;
• Abdominal pain;JA • Volume 186 Number 6 •  19 March 2007
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pation, diarrhoea, urgency, tenesmus;
• Family history of CRC, polyps or polyposis 
syndrome; and
• High risk of CRC, including radiological 
abnormalities and rectally palpable lesions.
About 11% of patients with indications 
such as weight loss and assessment of diver-
ticular disease did not fit into these broad 
groups.
The WA Government’s waiting-list reduc-
tion strategy, introduced in the second half 
of 2004, targeted certain procedural items, 
including colonoscopy. Individuals who had 
been waiting extended periods for colonos-
copy were offered places on procedural lists 
created by this initiative although, more 
recently, new referrals were also accepted. 
Procedures were performed by qualified 
specialists at secondary hospital sites after 
named referrals from general practitioners to 
that specialist, with proceduralist fees 
claimed through Medicare. Most patients 
were on the Category III waiting list. We 
compared waiting times over two time inter-
vals, 1 November 2003 – 31 October 2004 
(Period 1) and 1 November 2004 – 31 
October 2005 (Period 2), to determine 
whether this scheme had reduced waiting 
times for colonoscopy at Fremantle Hospital.
Statistical analysis
Data are expressed descriptively. Mann–
Whitney testing was used to determine dif-
ferences in median waiting times.
Waiting time to colonoscopy
The time to colonoscopy was examined using 
a generalised linear model approach, with 
days until colonoscopy the response, using a 
γ  response and inverse link. The fixed factors 
of urgency (Categories I, II or III), time period 
(Period 1, Period 2), and CRC (present, not 
present) were considered along with their 
respective interactions to determine whether 
these had an effect on the waiting time. In 
addition, results were adjusted for the demo-
graphic variables of sex and age.
Modelling CRC as outcome
Logistic regression was used to examine the 
binary response of CRC with possible pre-
dictors: sex, age (> or < 65 years), and the 
various indications for colonoscopy (blood-
loss indications, changes in bowel habits, 
follow-up examination, screening for family 
history, pain, and a suspected lesion), all 
considered in a backwards, stepwise selec-
tion approach. Significant predictors from 
the final model selected are presented, and 
odds ratios with 95% confidence intervals 
are given.
RESULTS
Over the 2-year period, 1771 outpatient 
colonoscopies were performed by the Endos-
copy Unit at Fremantle Hospital, with 1632 
patients meeting our inclusion criteria. The 
mean age of those undergoing colonoscopy 
was 59 years, and 51% were women. Com-
plete visualisation of the colon was achieved 
in 97% of procedures. The indications for 
colonoscopy are shown in Box 1.
Category I patients
Category I patients had short waiting times, 
well within the recommended time frame 
(Box 2), with a median waiting time of 17 
days. The detection rate of CRC was highest 
in this category — 12.2% of colonoscopies 
reported malignancy — but this included 
patients in whom there was a strong suspi-
cion of cancer (eg, lesions seen on radiologi-
cal examination, or palpable rectal masses). 
However, six of the 43 patients diagnosed 
with CRC waited more than 30 days for 
colonoscopy, with the maximum waiting 
time being 37 days.
Category II and III patients
Across the 2-year period, median waiting 
times for Category II and Category III 
patients were substantially longer than rec-
ommended at 113 and 258 days, respectively 
(Box 2). Nineteen Category II patients (2.4%) 
were diagnosed with cancer (18 CRC and one 
anal squamous cell carcinoma). Six of these 
19 patients waited more than 90 days, with 
four having blood-loss indications. Three 
Category III patients (0.6%) were diagnosed 
with cancer with a median waiting time of 
213 days. One patient with an indication of 
family history waited 463 days. Details of 
patients with CRC who waited more than the 
recommended category-specific number of 
days are shown in Box 3.
Risk factors for CRC
Age over 65 years and a raised suspicion of 
CRC before colonoscopy were significant risk 
factors for CRC on univariate analysis. All 
blood-loss indications taken together were 
not significantly associated with increased 
risk, although having iron deficiency/anaemia 
was a significant predictor of CRC diagnosis 
(CRC detection rate, 12%). No other indica-
tion group was associated with a significantly 
increased rate of CRC detection. Additionally, 
no sex-specific differences were observed in 
our cohort.
2 Number of patients with colorectal cancer (CRC) 
detected and waiting time by triage category over  
a 2-year period, November 2003 – October 2005







Mean age (years) 59   59   60
Median waiting time (days) 
to colonoscopy
17 113 258
CRC detected (no. [%]) 43 (12.2%) 19 (2.4%) 3 (0.6%)
Median waiting time (days) 
to CRC diagnosis
  7   43 213
Proportion of colonoscopies 
performed within time limit
81% 42% 36%
*  Recommended waiting times are: Category I, <  30 days; Category II,  
< 90 days; Category III, < 180 days.                                                                              ◆
1 Indications for colonoscopy by category of clinical urgency
Category of clinical urgency*










Strong suspicion  
of colorectal cancer
  5% 17%   3%   1%
Blood loss 28% 32% 37% 13%
Alteration in  
bowel function
21% 20% 26% 14%
Abdominal pain   8%   9% 10%   5%
Screening because 
of family history
11%   3%   7% 22%
Follow-up procedure 27% 11% 20% 48%
Other indications 12% 19% 12%   5%
* Recommended waiting times are: Category I, < 30 days; Category II,  
<  90 days; Category III, < 180 days.                                                                           ◆MJA • Volume 186 Number 6 •  19 March 2007 283
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age 65 years or over, positive 
results of an FOBT, iron defi-
ciency/anaemia, and a raised sus-
picion of CRC before colonoscopy 
were significant predictors of a 
diagnosis of CRC (Box 4).
Waiting time and CRC stage
To investigate the possibility that 
delayed colonoscopy may com-
promise cancer outcome, we 
compared waiting times for early-
stage CRC (Dukes A or B or stage 
T1 squamous cell carcinoma) and 
late-stage CRC (Dukes C or D) for 
cancers diagnosed within Catego-
ries II and III (Box 5). Patients 
with late-stage disease detected at 
colonoscopy had not experienced 
delayed colonoscopy compared 
with patients with early-stage dis-
ease, with median waiting times 
of 51 versus 43 days (difference 
not significant). Seventy per cent 
of patients with late-stage cancer 
had had colonoscopy within 90 
days compared with 54% of 
patients with early-stage cancer. 
In a logistic regression model, no 
demographic variable or proce-
dural indication predicted diag-
nosis of early-stage compared 
with late-stage CRC.
Factors affecting waiting time 
to colonoscopy
We evaluated variables that may 
have influenced whether colonos-
copy was performed within the 
recommended time frames. The 
tests of fixed effects indicated that there 
were differences in the three categories of 
urgency, as well as an effect of time period 
and whether or not the patient had CRC. 
Compared with the preceding year without 
the waiting-list reduction strategy, patients 
ultimately found to have CRC were more 
likely to have had a colonoscopy within the 
desirable time frame (odds ratio [OR], 2.6; 
95% CI, 1.3–5.1). Patients with no CRC 
were also more likely to have had a timely 
procedure (OR, 1.7; 95% CI, 1.2–2.5). Cat-
egory I patients were much more likely to 
have their procedure on time (OR, 7.5 for 
Category I compared with Category III), 
although there was no statistically signifi-
cant effect of a difference between Category 
II and Category III.
DISCUSSION
Our study has documented that waiting 
times for semi-urgent and routine colono-
scopies have exceeded institutional recom-
mendations for provision of colonoscopy in 
a public tertiary hospital. However, the can-
cer detection rate is not high in these Cat-
egory II and Category III patients, with CRC 
being detected in 2.4% and 0.6% of 
patients, respectively.
Our data show that the number of cancers 
detected is higher in patients aged 65 years 
or over and those who have indications for 
colonoscopy of a positive result of an FOBT, 
iron deficiency/anaemia, or a strong pre-test 
suspicion of CRC. These findings argue for 
prioritisation of these patients when book-
ing for colonoscopy, whereas currently, for 
example, positive results of an 
FOBT would be considered a Cat-
egory II indication. When there is 
a strong suspicion of cancer before 
colonoscopy, CRC is frequently 
confirmed, and the health system 
demonstrates a capacity to provide 
an appropriate service for patients 
with an urgent need for testing.
We have found no evidence to 
support a link between prolonged 
colonoscopy waiting time and 
stage of carcinoma at diagnosis. Of 
the eight patients with CRC whose 
waiting times exceeded clinically 
desirable parameters, there were 
five with early stage disease 
(Dukes A or B or a T1 anal squa-
mous cell carcinoma) and two 
with Dukes C disease (data on 
stage was not available for one 
patient). The median waiting 
times for colonoscopy for patients 
with early- and late-stage disease 
were 43 and 51 days, respectively. 
However, one patient triaged as 
Category II, who waited 313 days, 
was found to have Dukes C cancer 
and could potentially have bene-
fited from earlier diagnosis.
While few studies have investi-
gated colonoscopy delay and can-
cer outcome, there are data 
evaluating the impact of duration 
of symptoms before surgery. It has 
been suggested that a delay may 
be an adverse factor for rectal can-
cer stage at diagnosis, but not for 
colon carcinoma,5 although others 
have not found any negative asso-
ciation.6,7 Young et al reported 
that a delay of more than 3 
months was associated with lower 
likelihood of Stage A disease at 
surgery.8
Reducing waiting times for colonoscopy 
could be achieved by increasing endoscopic 
capacity and productivity or by rationalising 
service provision. The current ambulatory 
surgery initiative in operation at Fremantle 
Hospital uses an alternative funding mecha-
nism and allows new procedural lists to be 
created to take advantage of excess capacity 
within the state health system. The waiting-
list reduction initiative seems to have ena-
bled an increase in the proportion of 
patients having colonoscopy within accept-
able time frames. Other measures can also 
allow more colonoscopies to be performed, 
such as ensuring the appropriateness of 
procedures. Bampton et al studied the effect 
4 Predictors of increased risk of colorectal cancer (CRC) 
at colonoscopy (n = 1604)*
* Indication not listed for 28 patients.  
FOBT+ = positive result of a faecal occult blood test.                                   ◆
Variable
CRC detection rate, 
if indication present* 
Odds ratio
(95% CI)
Strong suspicion of CRC 27/85 (31.8%) 24.0 (13.0–44.1)
FOBT+ 2/14 (14.3%) 5.9 (1.2–29.7)
Iron deficiency/anaemia 12/98 (12.2%) 5.6 (2.7–11.8)
Age  65 years 41/642 (6.4%) 2.1 (1.2–3.8)
3 Patients in Category II and Category III diagnosed 
with colorectal cancer (CRC) after longer waiting 
times to colonoscopy than recommended for their 
triage category
* This patient was originally triaged to Category II but the booking was 
rescheduled and the patient did not attend. CRC was detected 12 months 
later when she participated in a flexible sigmoidoscopy CRC screening trial 
and an urgent colonoscopy was arranged. 
FOBT+ = positive result of a faecal occult blood test. 












M/70 Anaemia/FOBT+ 313 Dukes C




F/56 FOBT+ 210 T1 SCC
M/81 Altered bowel habit 108 Dukes C
F/73 Weight loss/diarrhoea 228 Dukes B
Category III
M/78 Family history of CRC/ 
altered bowel habit
213 Dukes A
M/57 Family history of CRC 463 Dukes A284 MJA • Volume 186 Number 6 •  19 March 2007
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and Medical Research Council (NHMRC) 
guidelines9 within an endoscopy unit. After 
the intervention, the proportion of post-
polypectomy surveillance decisions match-
ing the guidelines increased from 37% to 
96%, with a 23% reduction in the number 
of post-polypectomy surveillance colono-
scopies performed per year.10 Likewise, a 
17% reduction in colonoscopies performed 
on the basis of family history was achieved. 
Yusoff et al reviewed the appropriateness at 
their institution of referrals for colonoscopy 
for a family history of CRC and surveillance 
after CRC resection. Almost half of the 
patients referred because of a family history 
of CRC did not meet NHMRC guidelines.11
It was also concluded that surveillance 
colonoscopies after CRC resection were per-
formed too frequently and the release of 
NHMRC guidelines had not changed prac-
tice. Only one patient with CRC was found 
in 990 such examinations.12
Managing current demand for colonos-
copy has become an increasingly important 
issue with the imminent roll-out of a 
national CRC screening program in Aus-
tralia based on FOBT. A trial of FOBT 
screening in the United Kingdom resulted in 
a 21%–31% increase in demand for colon-
oscopy at participating hospitals due to 
increased screening procedures and, at 
times, a near doubling of waiting time for 
symptomatic patients.4 Evaluation of data 
collected during the Australian Bowel Can-
cer Screening Pilot Program suggests that 
the number of colonoscopy referrals gener-
ated from the target screening group may be 
up to 50% more than the number of positive 
results of FOBT, because of factors such as 
increased awareness of family history and 
gastrointestinal symptoms.3
Our data are subject to certain limitations. 
Within the three categories of urgency, 
patients may still be triaged with a more 
specific time frame for colonoscopy; for 
example “<  4 months” or “routine”, based on 
a decision by the reviewing specialist. This 
may also be influenced by whether the 
referral is for direct access to colonoscopy or 
after clinical review of the patient. Category 
III patients are particularly subject to this, 
making interpretation of the broad range of 
waiting times in this category (8–1126 days) 
difficult. Category II data, predominantly 
relating to symptomatic patients, are more 
robust, and it is in Category II patients that 
improved waiting times are likely to be of 
most benefit.
In conclusion, our study shows that wait-
ing times for colonoscopy for Category II 
and Category III patients have been longer 
than clinically desirable, although the 
number of cancers detected in these groups 
was low. Waiting-list reduction initiatives 
are capable of reducing waiting times for 
semi-urgent colonoscopy; however, longer 
waiting times do not appear to be associated 
with an increased risk of late-stage CRC. 
The recognition of risk factors for a diagno-
sis of cancer, including age over 65 years 
and certain blood-loss indications, could 
ensure that most patients with cancer are 
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5 Comparison of waiting times to 
colonoscopy for patients 
diagnosed with early- or late-stage 
colorectal cancer — Category II 
and Category III patients
Cancer stage
Early* Late†
Number of patients 11 10
Mean age (years) 66 74
Median waiting time (days) 43‡ 51‡





*  Early stage =  Dukes A or B if colorectal cancer, or a 
T1 stage squamous cell carcinoma.
† Late stage  =  Dukes C or D.
‡ Difference between early- and late-stage disease 
not significant by Mann–Whitney test.                     ◆MJA • Volume 186 Number 6 •  19 March 2007 285
